Universidad Peruana Cayetano Heredia
Clinical trials sponsored by Universidad Peruana Cayetano Heredia, explained in plain language.
-
Could one dose beat two? new trial tests simpler treatment for parasitic liver disease
Disease control Not yet recruitingThis study tests whether one or two doses of the drug oxfendazole can cure chronic fascioliasis (a liver infection caused by a parasite) as well as the standard two-dose treatment with triclabendazole. About 336 adults in Peru will be randomly assigned to one of three groups. Res…
Phase: PHASE2 • Sponsor: Universidad Peruana Cayetano Heredia • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a single dose beat brain worms? new trial aims to find out
Disease control Not yet recruitingThis study tests a drug called oxfendazole for people with mild brain cysticercosis, a parasitic infection that can cause seizures. Researchers will compare a single dose and three doses of oxfendazole against the standard combination therapy. The goal is to see if oxfendazole cl…
Phase: PHASE2, PHASE3 • Sponsor: Universidad Peruana Cayetano Heredia • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC